In a direct head-to-head comparison, tirzepatide demonstrated similar benefits in reducing MACE as semaglutide
However, one study found that headaches occurred slightly more often in people taking tirzepatide than the placebo: 9.4% of people taking Zepbound or Mounjaro reported headache, compared to 7.5% taking a placebo
As with any medication, there are potential side effects, including nausea, vomiting, diarrhea, and constipation, and it may not be suitable for everyone
While some experience noticeable shedding, others report no changes in their hair
Conclusion: Not Just a Supplement, A Cellular Shield Whether you're dealing with fatty liver, poor digestion, chronic cough, brain fog, or fatigue, the TUDCA + NAC combination targets the foundational issues: inflammation, oxidative stress, poor bile flow, and impaired cellular detox
The researchers found that plasma CoQ10 concentrations were significantly and consistently lower in the ME/CFS patient group